Cytokines in osteoblast-conditioned medium promote the migration of breast cancer cells

Tumor Biology

Volumn 35, Issue 1, 2014, Pages 791-798

  Chen, Xiaojia ^a,b   Lu, Jia ^a,b   Ji, Yuhua ^a,b   Hong, An ^a,b   Xie, Qiuling ^a,b  

^a Guangdong Provincial Key Laboratory of Bioengineering Medicine   (China)

^b National Engineering Research Center of Genetic Medicine   (China)

Author keywords

Bone microenvironment; Breast cancer; Cytokines; Osteoblast conditioned medium (OCM)

Indexed keywords

ACTIVIN A; ADIPONECTIN; CCL1 CHEMOKINE; CYTOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GROWTH DIFFERENTIATION FACTOR 15; INTERCELLULAR ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 2; INTERLEUKIN 12 RECEPTOR BETA2; INTERLEUKIN 13; INTERLEUKIN 17 RECEPTOR; INTERLEUKIN 3; INTERLEUKIN 6; INTERLEUKIN 8; INTERLEUKIN 9; MATRIX METALLOPROTEINASE 19; MATRIX METALLOPROTEINASE 20; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; OSTEOPROTEGERIN; PROTEIN KINASE B; SMAD4 PROTEIN; STROMELYSIN 2; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN;

ARTICLE; BREAST CANCER; CANCER CELL; CELL DIFFERENTIATION; CELL MIGRATION; CELL STRAIN MCF 7; CELL STRUCTURE; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE RELEASE; DOWN REGULATION; ENZYME ACTIVITY; GENE EXPRESSION; OSTEOBLAST; OSTEOBLAST CONDITIONED MEDIUM; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; UPREGULATION;

BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CULTURE MEDIA, CONDITIONED; CYTOKINES; FEMALE; HUMANS; MCF-7 CELLS; OSTEOBLASTS; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 84894464141     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-013-1109-0     Document Type: Article

References (47)

1. McKnight DAC, Sosnoski DM, Koblinski JE, Gay CV. Roles of osteonectin in the migration of breast cancer cells into bone. Journal of Cellular Biochemistry. 2006;97:288-302.
2. Mundy GR. Metastasis: metastasis to bone: causes, consequences and therapeutic opportunities. Nature Reviews Cancer. 2002;2:584-93.
3. Shan H, Takahashi T, Bando Y, Izumi K, Uehara H. Inhibitory effect of soluble platelet-derived growth factor receptor β on intraosseous growth of breast cancer cells in nude mice. Cancer Science. 2011;102:1904-10.
4. Roodman GD. Mechanisms of bone metastasis. New England Journal of Medicine. 2004;350:1655-64.
5. Tang CH, Chuang JY, Fong YC, Maa MC, Way TD, Hung CH. Bone-derived SDF-1 stimulates IL-6 release via CXCR4, ERK and NF-κB pathways and promotes osteoclastogenesis in human oral cancer cells. Carcinogenesis. 2008;29:1483-92.
6. Mundy GR, Yoneda T. Facilitation and suppression of bone metastasis. Clin Orthop. 1995;312:34-44.
7. Thomas RJ, Guise T, Yin JJ, Elliott J, Horwood NJ, Martin TJ, et al. Breast cancer cells interact with osteoblasts to support osteoclast formation. Endocrinology. 1999;140:4451-8.
8. Kakonen S-M, Mundy GR. Mechanisms of osteolytic bone metastases in breast carcinoma. Cancer. 2003;97:834-9.
9. Vurusaner B, Poli G, Basaga H. Tumor suppressor genes and ROS: complex networks of interactions. Free Radic Biol Med. 2012;52:7-18.
10. Wei Y-Y, Chen Y-J, Hsiao Y-C, Huang Y-C, Lai T-H, Tang C-H. Osteoblasts-derived TGF-β1 enhance motility and integrin upregulation through Akt, ERK, and NF-κB-dependent pathway in human breast cancer cells. Molecular Carcinogenesis. 2008;47:526-37.
11. Hanahan D,Weinberg RA. The hallmarks of cancer. Cell. 2000;100: 57-70.
12. Liu C, Dalby B, Chen W, Kilzer JM, Chiou HC. Transient transfection factors for high-level recombinant protein production in suspension cultured mammalian cells. Molecular Biotechnology. 2008;39: 141-53.
13. Makuch LA, Sosnoski DM, Gay CV. Osteoblast-conditioned media influence the expression of E-selectin on bone-derived vascular endothelial cells. Journal of Cellular Biochemistry. 2006;98:1221-9.
14. Brama M, Basciani S, Cherubini S, Mariani S, Migliaccio S, Arizzi M, et al. Osteoblast-conditioned medium promotes proliferation and sensitizes breast cancer cells to imatinib treatment. Endocrine Related Cancer. 2007;14:61-72.
15. Lai T-H, Fong Y-C, Fu W-M, Yang R-S, Tang C-H. Osteoblastsderived BMP-2 enhances the motility of prostate cancer cells via activation of integrins. The Prostate. 2008;68:1341-53.
16. Fong Y-C, Maa M-C, Tsai F-J, Chen W-C, Lin J-G, Jeng L-B, et al. Osteoblast-derived TGF-β1 stimulates IL-8 release through AP-1 and NF-κB in human cancer cells. Journal of Bone and Mineral Research. 2008;23:961-70.
17. Nannuru KC, Sharma B, Varney ML, Singh RK. Role of chemokine receptor CXCR2 expression in mammary tumor growth, angiogenesis and metastasis. J Carcinog. 2011;10:40.
18. Soikkeli J, Podlasz P, Yin M, Nummela P, Jahkola T, Virolainen S, et al. Metastatic outgrowth encompasses COL-I, FN1, and POSTN up-regulation and assembly to fibrillar networks regulating cell adhesion, migration, and growth. Am J Pathol. 2010;177:387-403.
19. Zeng G, Cai S, Liu Y, Wu GJ. METCAM/MUC18 augments migration, invasion, and tumorigenicity of human breast cancer SK-BR-3 cells. Gene. 2012;492:229-38.
20. PoettlerM,UnseldM,Mihaly-Bison J,Uhrin P, Koban F, Binder BR, et al. The urokinase receptor (CD87) represents a central mediator of growth factor-induced endothelial cell migration. Thromb Haemost. 2012;108:357-66.
21. Christgen M, Bruchhardt H, BallmaierM, Krech T, Langer F, Kreipe H, et al. KAI1/CD82 is a novel target of estrogen receptor-mediated gene repression and downregulated in primary human breast cancer. Int J Cancer. 2008;123:2239-46.
22. Cho SG, Li D, Stafford LJ, Luo J, Rodriguez-VillanuevaM,Wang Y, et al. KiSS1 suppresses TNFalpha-induced breast cancer cell invasion via an inhibition of RhoA-mediated NF-kappaB activation. J Cell Biochem. 2009;107:1139-49.
23. Mahabeleshwar GH, Kundu GC. Syk, a protein-tyrosine kinase, suppresses the cell motility and nuclear factor kappa b-mediated secretion of urokinase type plasminogen activator by inhibiting the phosphatidylinositol 3′-kinase activity in breast cancer cells. J Biol Chem. 2003;278:6209-21.
24. Palena C, Hamilton DH, Fernando RI. Influence of IL-8 on the epithelial-mesenchymal transition and the tumor microenvironment. Future Oncol. 2012;8:713-22.
25. Lei X, Pathak SP, Fukumura D. Hypoxia-induced activation of p38 mitogen-activated protein kinase and phosphatidylinositol 3′-kinase signaling pathways contributes to expression of interleukin 8 in human ovarian carcinoma cells. Clinical Cancer Research. 2004;10: 701-7.
26. Benoy IH. Increased serum interleukin-8 in patients with early and metastatic breast cancer correlates with early dissemination and survival. Clinical Cancer Research. 2004;10:7157-62.
27. Veltri RW, Miller MC, Zhao G, NG A,Marley GM,Wright GL, et al. Interleukin-8 serum levels in patients with benigh prostatic hyperplasia and prostate cancer. UROLOGY. 1999;53:139-47.
28. Xu L, Fidler IJ. Acidic pH-induced elevation in interleukin 8 expression by human ovarian carcinoma cells. Cancer Research. 2000;60: 4610-6.
29. Singh RK, Gutman M, Radinsky R, Bucana CD, FidIer IJ. Expression of interleukin 8 correlates with the metastatic potential of human melanoma cells in nude mice. Cancer Research. 1994;54: 3242-7.
30. Brat DJ, Bellai AC, Meir EGV. The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis. Neuro- Oncology. 2005;7:122-33.
31. Tedgui A, Mallat Z. Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev. 2006;86:515-81.
32. Inoue K, Slaton JW, Kim SJ, Perrotte P, Eve BY, Bar-Eli M, et al. Interleukin 8 expression regulates tumorigenicity and metastasis in human bladder cancer. Cancer Research. 2000;60:2290-9.
33. De Larco JE. The potential role of neutrophils in promoting the metastatic phenotype of tumors releasing interleukin-8. Clinical Cancer Research. 2004;10:4895-900.
34. Luca M, Huang S, Gershenwald JE, Singh RK, Reicht R, Bar-Eli M. Expression of interleukin-8 by human melanoma cells up-regulates MMP-2 activity and increases tumor growth and metastasis. American Journal of Pathology. 1997;151:1105-13.
35. Yatsunamia J, Tsurutaa N, Ogataa K,Wakamatsua K, Takayamaa K, KawasakiaM, et al. Interleukin-8 participates in angiogenesis in nonsmall cell, but not small cell carcinoma of the lung. Cancer Letters. 1997;120:101-8.
36. Araki S, Omori Y, Lyn D, Singh RK, Meinbach DM, Sandman Y, et al. Interleukin-8 is a molecular determinant of androgen independence and progression in prostate cancer. Cancer Research. 2007;67: 6854-62.
37. Yao C, Lin Y, Chua M-S, Ye C-S, Bi J, Li W, et al. Interleukin-8 modulates growth and invasiveness of estrogen receptor-negative breast cancer cells. International Journal of Cancer. 2007;121:1949-57.
38. Chaudhary LR, Avioli LV. Dexamethasone regulates IL-1β and TNF-a induced interleukin-8 production in human bone marrow stromal and osteoblast-like cells. Calcif Tissue Int. 1994;55:16-20.
39. Collin-Osdoby RL, Chen Y, Sunyer T, Chaudhary L, Tsay A, Goldring S, et al. Human osteoclasts and osteoclastlike cells synthesize and release high basal and inflammatory stimulated levels of the potent chemokine interleukin-8. Endocrinology. 1998;139:4353-63.
40. Bronner F, Farach-CarsonMC. Inflammatory cytokines and their role in bone metastasis and osteolysis. Bone and Cancer. 2009;5:141-55.
41. Nishizuka I, Ishikawa T, Hamaguchi Y, Kamiyama M, Ichikawa Y, Kadota K, et al. Analysis of gene expression involved in brain metastasis from breast cancer using CDNA microarray. Breast Cancer. 2002;9:26-32.
42. Waugh DJJ,Wilson C. The interleukin-8 pathway in cancer. Clinical Cancer Research. 2008;14:6735-41.
43. Santini D, Schiavon G, Vincenzi B, Gaeta L, Pantano F, Russo A, et al. Receptor activator of NF-kB (RANK) expression in primary tumors associates with bone metastasis occurrence in breast cancer patients. PLoS One. 2011;6:1-9.
44. Eubank TD, Roberts RD, Khan M, Curry JM, Nuovo GJ, Kuppusamy P, et al. Granulocyte macrophage colony-stimulating factor inhibits breast cancer growth and metastasis by invoking an anti-angiogenic program in tumor-educated macrophages. Cancer Research. 2009;69:2133-40.
45. Kohn EC, Hollister GH, DiPersio JD, Wahl S, Liotta LA, Schiffmann E. Granulocyte-macrophage colony-stimulating factor induces human melanoma-cell migration. Int J Cancer. 1993;53:968-72.
46. Jiang W, Xiang C, Cazacu S, Brodie C, Mikkelsen T. Insulin-like growth factor binding protein 7 mediates glioma cell growth and migration. Neoplasia. 2008;10:1335-42.
47. Amemiya Y, Yang W, Benatar T, Nofech-Mozes S, Yee A, Kahn H, et al. Insulin like growth factor binding protein-7 reduces growth of human breast cancer cells and xenografted tumors. Breast Cancer Research and Treatment. 2011;126:373-84.